{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:26:53Z","timestamp":1793957213456,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013252","name":"TG Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107894","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:26:36Z","timestamp":1788222396000},"page":"107894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epidemiologic, clinical and diagnostic characteristics of late-onset multiple sclerosis compared with adult-onset multiple sclerosis"],"prefix":"10.1016","volume":"115","author":[{"given":"Christoph","family":"H\u00fcneke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ellenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Stahmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4655-774X","authenticated-orcid":false,"given":"Niklas","family":"Frahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107894_bib0001","doi-asserted-by":"crossref","first-page":"289","DOI":"10.20344\/amp.11187","article-title":"Diagnostic delay of multiple sclerosis in a Portuguese population","volume":"32","author":"Aires","year":"2019","journal-title":"Acta Med. Port."},{"key":"10.1016\/j.msard.2026.107894_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165846","article-title":"Is time to reach EDSS 6.0 faster in patients with late-onset versus young-onset multiple sclerosis?","volume":"11","author":"Alroughani","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2026.107894_bib0003","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jamaneurol.2021.1008","article-title":"Risk of persistent disability in patients with pediatric-onset multiple sclerosis","volume":"78","author":"Baroncini","year":"2021","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2026.107894_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.829331","article-title":"Late-onset ms: disease course and safety-efficacy of DMTS","volume":"13","author":"Buscarinu","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107894_bib0005","first-page":"S69","article-title":"What we learned from the history of multiple sclerosis measurement: expanded disability status scale","volume":"55","author":"\u00c7inar","year":"2018","journal-title":"Noro Psikiyatr. Ars."},{"key":"10.1016\/j.msard.2026.107894_bib0006","doi-asserted-by":"crossref","DOI":"10.1177\/17590914221118502","article-title":"Multiple sclerosis and aging: the dynamics of demyelination and remyelination","volume":"14","author":"Correale","year":"2022","journal-title":"ASN Neuro"},{"key":"10.1016\/j.msard.2026.107894_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102893","article-title":"Immunosenescence in multiple sclerosis: the identification of new therapeutic targets","volume":"20","author":"Dema","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2026.107894_bib0008","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1007\/s00415-024-12384-3","article-title":"Management of multiple sclerosis in older adults: review of current evidence and future perspectives","volume":"271","author":"DiMauro","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107894_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1379538","article-title":"Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review","volume":"15","author":"Fern\u00e1ndez","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107894_bib0011","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00415-023-11905-w","article-title":"Real-life evaluation of the 2017 McDonald criteria for relapsing-remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis","volume":"271","author":"Ferrand","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107894_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103281","article-title":"Characteristics of secondary progressive multiple sclerosis: disease activity and provision of care in Germany \u2013 A registry-based\/multicentric cohort study","volume":"56","author":"Frahm","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107894_bib0013","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.2174\/1381612827666210728102832","article-title":"Polypharmacy in chronic neurological diseases: multiple sclerosis, dementia and Parkinson\u2019s disease","volume":"27","author":"Frahm","year":"2021","journal-title":"CPD"},{"key":"10.1016\/j.msard.2026.107894_bib0009","unstructured":"German Federal Statistical Office, 2023. Population by age group. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Bevoelkerung\/Bevoelkerungsstand\/Tabellen\/liste-altersgruppen-basis-2022.html (accessed 6.9.26)."},{"key":"10.1016\/j.msard.2026.107894_bib0014","doi-asserted-by":"crossref","first-page":"7756","DOI":"10.3390\/ijms26167756","article-title":"Refining prognostic factors in adult-onset multiple sclerosis: a narrative review of current insights","volume":"26","author":"Guerra","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107894_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/a-1898-2435","article-title":"Neue Therapieans\u00e4tze bei multipler sklerose inkl. stellenwert \u00e4lterer pr\u00e4parate","volume":"06","author":"Inojosa","year":"2023","journal-title":"Neurologie up2date"},{"key":"10.1016\/j.msard.2026.107894_bib0016","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/medicina56040170","article-title":"Is initial misdiagnosis associated with reaching disability milestones in patients with multiple sclerosis?","volume":"56","author":"Ivaniuk","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.msard.2026.107894_bib0017","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1177\/1352458520985118","article-title":"Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care","volume":"27","author":"Jalusic","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107894_bib0018","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/aje\/kwv445","article-title":"Comparison of statistical approaches for dealing with immortal time bias in drug effectiveness studies","volume":"184","author":"Karim","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.msard.2026.107894_bib0019","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00415-008-0778-x","article-title":"Clinical characteristics of patients with late-onset multiple sclerosis","volume":"255","author":"Kis","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107894_bib0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.26843","article-title":"Comparing the pathology, clinical, and demographic characteristics of younger and older-onset multiple sclerosis","volume":"95","author":"Knowles","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107894_bib0021","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/biomedicines10071629","article-title":"Diagnostic cerebrospinal fluid biomarker in early and late onset multiple sclerosis","volume":"10","author":"Konen","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.msard.2026.107894_bib0022","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/brain\/aww173","article-title":"Defining secondary progressive multiple sclerosis","volume":"139","author":"Lorscheider","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107894_bib0023","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1590\/0004-282x20170070","article-title":"Late onset multiple sclerosis: concerns in aging patients","volume":"75","author":"Lotti","year":"2017","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2026.107894_bib0024","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/brain\/awaa081","article-title":"Early clinical markers of aggressive multiple sclerosis","volume":"143","author":"Malpas","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107894_bib0025","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1002\/mrm.29152","article-title":"High-resolution quantitative MRI of multiple sclerosis spinal cord lesions","volume":"87","author":"McDowell","year":"2022","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.msard.2026.107894_bib0026","article-title":"Neurodegeneration in multiple sclerosis","volume":"15","author":"Mey","year":"2023","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.msard.2026.107894_bib0027","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/jcm9051326","article-title":"Clinical characteristics and disability progression of early- and late-onset multiple sclerosis compared to adult-onset multiple sclerosis","volume":"9","author":"Mirmosayyeb","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.msard.2026.107894_bib0028","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208051","article-title":"Clinical characteristics and long-term outcomes of late-onset multiple sclerosis: a Swedish nationwide study","volume":"102","author":"Mouresan","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107894_bib0029","series-title":"Number of People with MS | Atlas of MS","year":"2023"},{"key":"10.1016\/j.msard.2026.107894_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102816","article-title":"Clinical features of late-onset multiple sclerosis: a systematic review and meta-analysis","volume":"50","author":"Naseri","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107894_bib0031","doi-asserted-by":"crossref","first-page":"725","DOI":"10.34172\/aim.2022.114","article-title":"Clinical and epidemiological aspects of late onset multiple sclerosis in east-Azerbaijan, Iran; a population-based study","volume":"25","author":"Nasiri","year":"2022","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.msard.2026.107894_bib0032","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neurad.2023.08.002","article-title":"Radiological features of late-onset multiple sclerosis: a systematic review and meta-analysis","volume":"50","author":"Nasiri","year":"2023","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.msard.2026.107894_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92722-x","article-title":"Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry","volume":"11","author":"Ohle","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107894_bib0034","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nrl.2020.05.016","article-title":"Immunosenescence: the role of age in multiple sclerosis","volume":"38","author":"Ostolaza Ib\u00e1\u00f1ez","year":"2023","journal-title":"Neurologia (Engl. Ed)"},{"key":"10.1016\/j.msard.2026.107894_bib0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fncel.2020.00178","article-title":"Aging, cellular senescence, and progressive multiple sclerosis","volume":"14","author":"Papadopoulos","year":"2020","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.msard.2026.107894_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103361","article-title":"Factors driving delayed time to multiple sclerosis diagnosis: results from a population-based study","volume":"57","author":"Patti","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107894_bib0037","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s13365-017-0561-9","article-title":"Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy","volume":"23","author":"Prosperini","year":"2017","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.msard.2026.107894_bib0038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12883-025-04172-x","article-title":"Multiple sclerosis patients\u2019 journey delay in diagnosis and treatment: a multicenter study","volume":"25","author":"Ragab","year":"2025","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2026.107894_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/451912","article-title":"Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment","volume":"2015","author":"Shirani","year":"2015","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.msard.2026.107894_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105830","article-title":"Safety of high efficacy therapies in older people with Multiple Sclerosis: a real-world evidence study","volume":"90","author":"Silva","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107894_bib0041","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00415-026-13632-4","article-title":"Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry","volume":"273","author":"Souissi","year":"2026","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107894_bib0042","doi-asserted-by":"crossref","DOI":"10.1177\/17562864261430084","article-title":"Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry","volume":"19","author":"Surcinelli","year":"2026","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2026.107894_bib0043","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00415-026-13858-2","article-title":"Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study","volume":"273","author":"Surcinelli","year":"2026","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107894_bib0044","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/13524585231197076","article-title":"Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences","volume":"29","author":"Uher","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107894_bib0045","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1111\/ene.15006","article-title":"First-line therapies in late-onset multiple sclerosis: an Italian registry study","volume":"28","author":"Zangh\u00ec","year":"2021","journal-title":"Eur. J. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:40:25Z","timestamp":1793954425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826009296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"alternative-id":["S2211034826009296"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107894","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiologic, clinical and diagnostic characteristics of late-onset multiple sclerosis compared with adult-onset multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107894"}}